Dr. Trent is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1475 NW 12th Ave
Fl 1
Miami, FL 33136Phone+1 305-243-2581Fax+1 305-243-1293
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2002- University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1995 - 1998
McGovern Medical School at UTHealthClass of 1995
Certifications & Licensure
FL State Medical License 2011 - 2026
TX State Medical License 1997 - 2013- National Board of Physicians and Surgeons Internal Medicine
- National Board of Physicians and Surgeons Medical Oncology
- The National Board of Physicians and SurgeonsMedical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Oblimersen and Imatinib Mesylate in Treating Patients With Advanced Gastrointestinal Stromal Tumors That Cannot Be Removed By Surgery Start of enrollment: 2005 Sep 01
- Ph II Study of Perifosine Plus Gleevec for Patients With GIST Start of enrollment: 2006 Aug 01
- Preoperative and Postoperative Imatinib Mesylate Study in Patients With c-Kit Positive GIST Start of enrollment: 2003 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 45 citationsDeletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma.Jilong Yang, David Cogdell, Da Yang, Limei Hu, Haixin Li
Cancer Letters. 2010-05-01 - 101 citationsGenetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma.Jilong Yang, Da Yang, Yan Sun, Baocun Sun, Guowen Wang
Cancer. 2011-11-01 - 267 citationsA Missense Mutation in KIT Kinase Domain 1 Correlates with Imatinib Resistance in Gastrointestinal Stromal TumorsLei L. Chen, Jonathan C. Trent, Elsie F. Wu, Gregory N. Fuller, Latha Ramdas
Cancer Research. 2004-09-01
Press Mentions
Sylvester Recruits Aman Chauhan, M.D., to Lead Neuroendocrine Tumor ProgramMarch 16th, 2023- Sylvester Stands Out at ASCO’s 2022 Annual Meeting in ChicagoJune 21st, 2022
- Precision Medicine Advances in Cancer Treatment Highlighted at Inaugural Sylvester ConferenceApril 12th, 2022
- Join now to see all
Grant Support
- Chaperonin (Sulfolobus Shibatae)National Center For Research Resources2006–2009
- Activity &Resistance Of Gleevec In GI Stromal TumorsNational Cancer Institute2004–2008
- Mechanism/Activity/Resistance/Gleevec/Gi Stromal Tumors (K23M)National Cancer Institute2005–2006
- Chaperonins As Self-Assembling Building Blocks For NanotechnologyNational Center For Research Resources2005
- Characterize Struct Of Molecular Chaperones Cytostructure Of Prokaryotic CellNational Center For Research Resources1998
- Chaperonin Filaments Archaeal CytostructureNational Center For Research Resources1998
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
